Company research

Explore company profiles, quarterly results, announcements and ownership disclosures.

Loading the company view…

Onesource Specialty Pharma Limited (ONESOURCE) — Stock Analysis

Onesource Specialty Pharma Limited (NSE: ONESOURCE), ISIN INE013P01021 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.

ONESOURCE last traded at ₹1617.30 (-0.94%), with a 52-week range of ₹1057.00 to ₹1917.80 (as of 6 Nov 2026).

Shareholding as of Sep 2026: promoters 30.47%, FIIs 19.45%, DIIs 24.20%, mutual funds 13.76%.

EquiSense Score (ECS): 79/100.

Data sourced from NSE and BSE filings. Educational — not investment advice.